<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02292251</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00047647</org_study_id>
    <nct_id>NCT02292251</nct_id>
  </id_info>
  <brief_title>Study to Enhance Motor Acute Recovery With Intensive Training After Stroke</brief_title>
  <acronym>SMARTS2</acronym>
  <official_title>Study to Enhance Motor Acute Recovery With Intensive Training After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>James S McDonnell Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke often results in limitation of arm movements, from which many people do not fully
      recover. We believe that early and intensive therapy is important to enhance recovery of arm
      movements after stroke. We are doing this research study to see how much arm movements
      improve with intensive therapy in patients have had a stroke in the past 6 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">April 2018</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl-Meyer Upper Extremity (FM-UE)</measure>
    <time_frame>from baseline to day 3 post-training</time_frame>
    <description>Change in arm impairment, measured by FM-UE</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer Upper Extremity (FM-UE)</measure>
    <time_frame>from baseline to day 90 post-training</time_frame>
    <description>Change in arm impairment, measured by FM-UE</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Device-assisted therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 hours of therapy with the ArmeoPower device, a commercially available device for arm rehabilitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapy-based occupational therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 hours of conventional occupational therapy that emphasizes task-oriented training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Device-assisted therapy</intervention_name>
    <arm_group_label>Device-assisted therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Therapy-based occupational therapy</intervention_name>
    <arm_group_label>Therapy-based occupational therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age over 21 years

          2. Ischemic stroke confirmed by CT or MRI within the previous 6 weeks

          3. No history of prior ischemic or hemorrhagic stroke with associated motor deficits
             (prior stroke with no motor symptoms is allowed)

          4. Residual unilateral arm weakness with Fugl-Meyer Upper Extremity (FM-UE) score 6-40 at
             time of enrollment.

          5. Ability to give informed consent and understand the tasks involved.

        Exclusion Criteria:

          1. Space-occupying hemorrhagic transformation or associated intracranial hemorrhage.

          2. Arm impairment that is too severe or too mild on day of baseline testing just prior to
             beginning of the study intervention.

          3. Recent botox injection to upper limb or planned botox injection over the course of the
             7-month study duration.

          4. Cognitive impairment, with score on Montreal Cognitive Assessment (MoCA) â‰¤ 20.

          5. History of physical or neurological condition that interferes with study procedures or
             assessment of motor function (e.g. severe arthritis, severe neuropathy, Parkinson's
             disease).

          6. Inability to sit in a chair and perform upper limb exercises for one hour at a time.

          7. Participation in another upper extremity rehabilitative therapy study during the study
             period.

          8. Terminal illness

          9. Social and/or personal circumstances that interfere with ability to return for therapy
             sessions and follow up assessments.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John W. Krakauer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Zurich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>November 8, 2014</study_first_submitted>
  <study_first_submitted_qc>November 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2014</study_first_posted>
  <last_update_submitted>August 8, 2018</last_update_submitted>
  <last_update_submitted_qc>August 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Transcranial direct current stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

